The journey from medicines management to optimisation has resulted in significant improvements in the quality and safety of medicines yielding health gain and economy and a return on investment of £5–8 for each £1 invested. How? Read the review.
‘A compilation of good practices’ – European Innovation Partnership on Active and Healthy Ageing is a booklet by Action Group A1 on Prescription and Adherence to Medical Plans.
The publication was prepared by the European Commission, DG SANCO, based on material send by members of the Action Group A1 in June-July 2013. The main contributors were Stefano Vettorazzi, Jorge Pinto Antunes, Isabelle Dévé, and Marianne van den Berg under the supervision Maria Iglesia Gomez, Head of Unit Innovation for Health and Consumers.
This paper introduces the concept of matrix models: a new project to ensure that there is clinically effective, safe and economic prescribing of medicines in an integrated manner, in both primary and secondary care, in Northern Ireland.
'A prelude to the Matrix Models', Mike Scott, Robert Janknegt & Robert Brenninkmeijer. In: Expert Opinion on Pharmacotherapy, October 2007, Vol. 8, suppl. 1, p.1-4
A number of medicine selection methods have been used worldwide for formulary purposes. In Northern Ireland, integrated medicines management is being developed, and related projects have been carried out. This paper deals with the description of the STEPS (Safe Therapeutic Economic Pharmaceutical Selection) programme. The paper outlines the development of STEPS and its application as an element of a cost-effective medicines-management process in Northern Ireland.
Drug selection should be a rational process that embraces the principles of evidence-based medicine. However, many factors may affect the choice of agent. It is against this background that the System of Objectified Judgement Analysis (SOJA) process for rational drug-selection was developed. This article describes how the information on which the SOJA process is based, was researched and processed.
InforMatrix is a decision matrix technique by means of which a group of experts on a subject (health condition) determine, on the basis of agreed criteria, an order of merit for the various available treatment options for that condition. The goal of the InforMatrix program is to make a rational selection of first-choice medications or drugs following the evaluation of the clinical value of available therapeutic agents.
This paper provides an overview of the use of matrix models within the context of Pharmacotherapy. It also discusses the application of these matrix models to the Safe Therapeutic Economic Pharmaceutical Selection (STEPS) approach used in Northern Ireland.
'Matrix models and STEPS: concluding remarks', Mike Scott, Mark Timoney, Jill Mairs, Grainne Crealey, Ibrahim Al Abaddi, Rob Brenninkmeijer, Rob Janknegt & James McElnay. In: Expert Opinion on Pharmacotherapy, October 2007, 8, suppl. 1, p.65-67